LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

Search

Allogene Therapeutics Inc

Closed

SectorHealthcare

1.9 1.6

Overview

Share price change

24h

Current

Min

1.8599999999999999

Max

1.92

Key metrics

By Trading Economics

Income

-3.8M

-43M

EPS

-0.18

Employees

150

EBITDA

-3.9M

-43M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+363.3% upside

Dividends

By Acuity

Next Earnings

12 Aug 2026

Market Stats

By TradingEconomics

Market Cap

-138M

649M

Previous open

0.3

Previous close

1.9

News Sentiment

By Acuity

29%

71%

80 / 344 Healthcare

Allogene Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Jun 2026, 23:06 UTC

Social Media
News
ETF Constituents

Invesco QQQ Trust Series I gains after-market, supported by a strong Nasdaq close and SpaceX's debut, maintaining stability since Friday's close.

12 Jun 2026, 20:07 UTC

News
Correlated Moves

The USD/DKK is trading higher, reflecting a modest increase since Thursday's close. The US Dollar Index also shows a slight uptick.

12 Jun 2026, 20:07 UTC

News

The USD/CZK is trading lower today, reflecting a slight decline since Thursday's close. Recent U.S. producer price data has not significantly impacted the currency pair.

12 Jun 2026, 20:07 UTC

News

Baker Hughes oil rig count rises to 433, influencing energy market sentiment. USD/PLN is trading roughly flat during Friday's session.

12 Jun 2026, 20:07 UTC

Correlated Moves
Macro Event
News

The U.S. Baker Hughes oil rig count increased to 433, while the Michigan Consumer Sentiment Index rose to a preliminary reading of 48.9. USD/SGD is trading roughly flat.

12 Jun 2026, 20:07 UTC

News

The U.S. Baker Hughes oil rig count rose to 433, while USD/THB trades roughly flat since Thursday's close amid routine market fluctuations.

12 Jun 2026, 20:07 UTC

News
Macro Event

The USD/SEK exchange rate is lower today, despite a rise in U.S. consumer sentiment reported at 48.9, above expectations.

12 Jun 2026, 20:07 UTC

News
Macro Event

USD/HUF trades lower despite a stronger-than-expected Michigan Consumer Sentiment Index, reflecting ongoing inflation concerns and unusual volatility during the session.

12 Jun 2026, 20:07 UTC

News

The USD/ZAR is higher, supported by an increase in the Baker Hughes oil rig count, reflecting dynamics in the energy sector impacting currency valuations.

12 Jun 2026, 20:02 UTC

News

ASML Holding NV is lower today, even as analysts note strengthening competitive advantages amid diminishing concerns over rival xLight and ongoing demand for its technology.

12 Jun 2026, 20:02 UTC

News

Amazon.com Inc. shares are declining amid broadline retail sector weakness, despite recognition of Amazon Web Services as a growth driver.

12 Jun 2026, 20:02 UTC

Macro Event
ETF Constituents
News
Macro News
Correlated Moves
Social Media

Financial Select Sector SPDR Fund is higher today, supported by gains in the financial sector and optimism over geopolitical stability following President Trump's Iran negotiations.

12 Jun 2026, 20:02 UTC

News
Social Media

Intel's stock rises as Bank of America upgrades to Buy and Google orders three million processing units, reflecting strong market sentiment and bullish options flow.

12 Jun 2026, 20:02 UTC

News

Cintas Corp shares are lower as the FTC issues a second request regarding its acquisition of UniFirst, signaling potential delays in the transaction.

12 Jun 2026, 20:02 UTC

News

Adobe Inc. shares are trading lower amid analyst downgrades and CFO Dan Durn's upcoming departure. Concerns over a freemium model pressure near-term revenue outlook.

12 Jun 2026, 20:01 UTC

News

Speculation about a merger involving Deutsche Telekom has boosted T-Mobile US shares. The stock has shown steady gains since Thursday's close, trading above its 20-day moving average.

12 Jun 2026, 19:56 UTC

News
Correlated Moves
Macro Event

Broadcom Inc shares declined as broader market dynamics and economic data weighed on sentiment, despite record Q2 revenue and AI growth.

12 Jun 2026, 19:52 UTC

News
Social Media

Workday Inc shares are lower today amid broader declines in the Application Software sector and an insider selling 107,500 shares at $135.54 to $140.37.

12 Jun 2026, 19:52 UTC

News
Correlated Moves
Social Media

Wells Fargo raised Qualcomm's price target to $230, contributing to positive sentiment. The stock is trading higher amid optimism for upcoming Investor Day.

12 Jun 2026, 19:52 UTC

News

Intuit Inc. shares are lower amid an investigation for securities fraud by Bleichmar Fonti & Auld LLP related to pricing issues for DIY tax filers.

12 Jun 2026, 19:51 UTC

News

Amgen Inc. is reassessing data on Tavneos amid FDA scrutiny. Shares are higher as the company challenges the proposal to withdraw the drug's approval.

12 Jun 2026, 19:51 UTC

News
ETF Constituents

Health Care Select Sector SPDR Fund declines as key holdings falter, underperforming against gains in Energy, Materials, and Financials sectors.

12 Jun 2026, 19:46 UTC

News
Social Media

Alphabet appeals a German court ruling on AI claims and announced a $50 million investment in workforce training, while shares are higher today.

12 Jun 2026, 19:42 UTC

News
Social Media

Meta Platforms shares are lower amid reports of widespread service outages affecting Instagram, Facebook, and WhatsApp, with over 62,000 complaints noted.

12 Jun 2026, 19:41 UTC

News

Analysts have raised earnings estimates for NetEase, reflecting positive sentiment. Shares are trading higher today, maintaining upward momentum since Thursday's close.

12 Jun 2026, 19:41 UTC

News
Correlated Moves
Social Media

Advanced Micro Devices shares rose after Citi upgraded its rating to Buy and raised the price target to $575, citing strong GPU market potential.

12 Jun 2026, 19:41 UTC

News
Correlated Moves

Applied Materials Inc is rising amid a broader market rally and Cantor Fitzgerald's price target increase to $650 from $575, reflecting strong investor interest.

12 Jun 2026, 19:41 UTC

Social Media
News

WDC shares gain as JPMorgan raises price target to $650.

12 Jun 2026, 19:41 UTC

Social Media
News
Correlated Moves
Macro Event

Lam Research Corp shares rise amid a market rally following President Trump's strike cancellation on Iran. Cantor Fitzgerald raised its price target to $425.

12 Jun 2026, 19:41 UTC

News

Comcast Corp shares are higher today, driven by gains in the Cable & Satellite sector. The stock remains above Thursday's close despite a slight pullback.

Peer Comparison

Price change

Allogene Therapeutics Inc Forecast

Price Target

By TipRanks

363.3% upside

12 Months Forecast

Average 8.71 USD  363.3%

High 14 USD

Low 3.85 USD

Based on 14 Wall Street analysts offering 12 month price targets forAllogene Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

12

Buy

2

Hold

0

Sell

Sentiment

By Acuity

80 / 344 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Allogene Therapeutics Inc

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma; and is in Phase 1b clinical trial for the treatment of chronic lymphocytic leukemia. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase 1 clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO-316, an allogeneic CAR T cell product candidate that is in Phase 1 clinical trial for the treatment of advanced or metastatic RCC; ALLO-329 for the treatment of certain autoimmune diseases; DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors; and Claudin 18.2 for the treatment of gastric and pancreatic cancer. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.
help-icon Live chat